You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Diffuse Large B-Cell Lymphomas in CNS

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma Trial run by the NCI (Rituximab,

Suspended
  • Burkitt Lymphoma
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Primary Diffuse Large B-cell Lymphoma of the CNS (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNS Trial

Suspended
  • Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
  • Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

Not yet recruiting
  • Follicular Lymphoma
  • +3 more
  • Tazemetostat Pill
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Jun 28, 2023

Hodgkin Lymphoma, DLBCL Trial run by the NCI (campath, Rituximab, EPOCH)

Completed
Has Results
  • Hodgkin Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • Campath
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 11, 2022

Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

Recruiting
  • Diffuse Large Cell Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Diffuse Large B Cell Lymphoma, CNS Metastasis Trial in Herlev

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Central Nervous System Metastasis
    • Herlev, Capital Region, Denmark
      Herlev Hopital
    Mar 21, 2022

    Predict CNS Involvement in Diffuse Large B-Cell Lymphoma:Danish

    Completed
    • Diffuse Large B Cell Lymphoma
    • +2 more
      • (no location specified)
      Dec 13, 2021

      Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

      Not yet recruiting
      • Lymphoma, B-Cell
      • +6 more
      • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
      • Guayaquil, Guayas, Ecuador
        Instituto Oncológico Nacional Dr. Juan Tanca Marengo
      Apr 27, 2023

      Tumor Heterogeneity in Diffuse Large B-cell Lymphoma in Relation

      Recruiting
      • Lymphoma, Large B-Cell, Diffuse
        • Copenhagen, Denmark
          Department of Hematology, Rigshospitalet
        Jan 12, 2022

        High-Dose Methotrexate Clearance in Diffuse Large B-Cell

        Recruiting
        • Central Nervous System Lymphoma
        • Diffuse Large B-Cell Lymphoma
        • Non-Interventional Study
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Sep 8, 2023

        Recurrent DLBCL, Refractory Diffuse Large B-cell Lymphoma Trial in Tianjin (RC19D2 cell injection)

        Recruiting
        • Recurrent Diffuse Large B-Cell Lymphoma
        • Refractory Diffuse Large B-cell Lymphoma
        • RC19D2 cell injection
        • Tianjin, Tianjin, China
          Hematology Hospital of the Chinese Academy of Medical Sciences
        Sep 14, 2023

        Diffuse Large B Cell Lymphoma | DLBCL Recurrent/Refractory Trial (ZR2-ICE)

        Not yet recruiting
        • Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Recurrent/Refractory
        • (no location specified)
        Sep 5, 2023

        Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory Trial in Hangzhou (Anlotinib HCl, Rituximab,

        Recruiting
        • Diffuse Large B-cell Lymphoma Recurrent
        • Diffuse Large B Cell Lymphoma Refractory
        • Anlotinib hydrochloride, Rituximab, gemcitabine, oxaliplatin
        • Hangzhou, Zhejiang, China
          Zhejiang Cancer Hospital
        Oct 12, 2023

        B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

        Not yet recruiting
        • B-cell Non-Hodgkin Lymphoma
        • +4 more
        • (no location specified)
        Dec 7, 2022

        Relapsed or Refractory Diffuse Large B-cell Lymphoma Trial in Beijing (BEBT-908 for injection)

        Active, not recruiting
        • Relapsed or Refractory Diffuse Large B-cell Lymphoma
        • BEBT-908 for injection
        • Beijing, China
          Cancer Hospital Chinese Academy of Medical Sciences
        Oct 8, 2023

        DLBCL Trial (Polatuzumab Vedotin)

        Not yet recruiting
        • Diffuse Large B-Cell Lymphoma
        • Polatuzumab Vedotin
        • (no location specified)
        Jul 12, 2023

        Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab vedotin and Rituximab)

        Recruiting
        • Diffuse Large B Cell Lymphoma
        • Zanubrutinib, Polatuzumab vedotin and Rituximab
        • Shanghai, Shanghai, China
          Zhongshan Hospital，Fudan University
        Jul 10, 2023

        DLBCL Trial in Jinan (Mitoxantrone Hydrochloride Liposome Injection)

        Not yet recruiting
        • Diffuse Large B-Cell Lymphoma
        • Mitoxantrone Hydrochloride Liposome Injection
        • Jinan, Shandong, China
          Affiliated Cancer Hospital of Shandong First Medical University
        May 16, 2023

        Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab Vedotin, Rituximab)

        Recruiting
        • Diffuse Large B Cell Lymphoma
        • Zanubrutinib, Polatuzumab Vedotin, Rituximab
        • Shanghai, Shanghai, China
          Zhongshan Hospital，Fudan University
        Jul 10, 2023

        CNS Lymphoma, Secondary CNS Lymphoma Trial run by the National Cancer Institute (NCI) (TEDD-R, TEDDI-R, Ibrutinib)

        Recruiting
        • Central Nervous System Lymphoma
        • Secondary Central Nervous System Lymphoma
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 23, 2023

        Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

        Recruiting
        • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
          • Milan, Italy
            Ospedale San Raffaele
          Aug 29, 2023

          Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Cyclophosphamide)

          Not yet recruiting
          • Diffuse Large B-cell Lymphoma
          • (no location specified)
          Mar 9, 2023

          DLBCL Trial (Acalabrutinib, Rituximab)

          Not yet recruiting
          • Diffuse Large B-Cell Lymphoma
          • (no location specified)
          Jul 11, 2023

          Lymphomas Non-Hodgkin's B-Cell Trial in Ballarat, Box Hill, Heidelberg (Avelumab)

          Active, not recruiting
          • Lymphomas Non-Hodgkin's B-Cell
          • Ballarat, Victoria, Australia
          • +2 more
          Jan 30, 2023

          Refractory Aggressive B-cell Lymphomas, Refractory B-Cell Non-Hodgkin Lymphoma, Aggressive B-cell NHL Trial in Boston

          Not yet recruiting
          • Refractory Aggressive B-cell Lymphomas
          • +12 more
          • Boston, Massachusetts
          • +1 more
          Oct 13, 2022